[Pharmacological study of parkinsonian tremor. I. Methods].
D000109:Acetylcholine / Q000378:metabolism; D000368:Aged; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006632:Histamine / Q000378:metabolism / Q000494:pharmacology; D006633:Histamine Antagonists / Q000494:pharmacology; D006801:Humans; D008297:Male; D008875:Middle Aged; D018377:Neurotransmitter Agents / Q000096:biosynthesis*; D010276:Parasympatholytics / Q000494:pharmacology; D010302:Parkinson Disease, Secondary / Q000378:metabolism*; D010830:Physostigmine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D017981:Receptors, Neurotransmitter / Q000187:drug effects*; D012701:Serotonin / Q000378:metabolism; D014149:Tranquilizing Agents / Q000494:pharmacology
D006633:Histamine Antagonists; D018377:Neurotransmitter Agents; D010276:Parasympatholytics; D010879:Piperazines; D017981:Receptors, Neurotransmitter; D014149:Tranquilizing Agents; D012701:Serotonin; D006632:Histamine; D010830:Physostigmine; D000109:Acetylcholine; D004298:Dopamine
Studio farmacologico del tremore parkinsoniano: I) metodologia.